Stem Cell-Derived Exosomes in Autism Spectrum Disorder
Open Access
- 4 February 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (3) , 944
Abstract
Neurodevelopmental lifelong pathologies defined by problems with social interaction, communication capacity and presence of repetitive/stereotyped clusters of behavior and interests are grouped under the definition of autism spectrum disorder (ASD). ASD prevalence is still increasing, indicating the need to identify specific biomarkers and novel pharmacotherapies. Neuroinflammation and neuro-immune cross-talk dysregulation are specific hallmarks of ASD, offering the possibility of treating these disorders by stem cell therapy. Indeed, cellular strategies have been postulated, proposed and applied to ASD. However, less is known about the molecular action mechanisms of stem cells. As a possibility, the positive and restorative effects mediated by stem cells could be due to their paracrine activity, by which stem cells produce and release several ameliorative and anti-inflammatory molecules. Among the secreted complex tools, exosomes are sub-organelles, enriched by RNA and proteins, that provide cell-to-cell communication. Exosomes could be the mediators of many stem cell-associated therapeutic activities. This review article describes the potential role of exosomes in alleviating ASD symptoms.Keywords
This publication has 77 references indexed in Scilit:
- Perspectives on the Use of Stem Cells for Autism TreatmentStem Cells International, 2013
- Extracellular vesicles: structure, function, and potential clinical uses in renal diseasesBrazilian Journal of Medical and Biological Research, 2013
- Epigenetic Findings in Autism: New Perspectives for TherapyInternational Journal of Environmental Research and Public Health, 2013
- Possible use of Trichuris suis ova in autism spectrum disorders therapyMedical Hypotheses, 2013
- Antibodies against Food Antigens in Patients with Autistic Spectrum DisordersBioMed Research International, 2013
- Autism Spectrum Disorders: Is Mesenchymal Stem Cell Personalized Therapy the Future?Journal of Biomedicine and Biotechnology, 2012
- Tumour microvesicles contain retrotransposon elements and amplified oncogene sequencesNature Communications, 2011
- Exosomes: Extracellular organelles important in intercellular communicationJournal of Proteomics, 2010
- Mesenchymal Stem Cells: Mechanisms of Immunomodulation and HomingCell Transplantation, 2010
- TNF RECEPTOR 2, NOT TNF RECEPTOR 1, ENHANCES MESENCHYMAL STEM CELL-MEDIATED CARDIAC PROTECTION FOLLOWING ACUTE ISCHEMIAShock, 2010